Some molecular and genetic markers might predict whether colorectal cancer patients are likely to benefit from adjuvant or salvage therapy.
一些分子或基因指标有可能预测大肠患者能否从辅助化疗或姑息化疗中获益。
Some molecular and genetic markers might predict whether colorectal cancer patients are likely to benefit from adjuvant or salvage therapy.
一些分子或基因指标有可能预测大肠患者能否从辅助化疗或姑息化疗中获益。
应用推荐